ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Betadine® desinfizierende Lösung:iNova Pharmaceuticals (Switzerland) AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Stand der Information

August 2024
1 Module 2, 2.5: Povidone-iodine, Clinical Overview Addendum for Safety Label Variation, 02 Nov 2021.
2 Module 2, 2.5: Mundipharma Research Ltd. Povidone-iodine and skin discolouration. September 28, 2021.
3 Module 2, 2.5: Povidone-iodine, Clinical Overview Addendum for Safety Label Variation, 02 Nov 2021.
4 Module 2, 2.5: Mundipharma Research Ltd. Povidone-iodine and skin discolouration. September 28, 2021.

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home